6109-54-2

Basic information

• Product Name: 2,5-Bis(benzyloxy)benzenecarbaldehyde
• Synonyms: 2,5-Bis(benzyloxy)benzenecarbaldehyde;2,5-Bis(benzyloxy)benzaldehyde
• CAS NO: 6109-54-2
• Molecular Formula: C₂₁H₁₈O₃
• Molecular Weight: 318
• Mol File: 6109-54-2.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: 2,5-Bis(benzyloxy)benzenecarbaldehyde(CAS DataBase Reference)
• NIST Chemistry Reference: 2,5-Bis(benzyloxy)benzenecarbaldehyde(6109-54-2)
• EPA Substance Registry System: 2,5-Bis(benzyloxy)benzenecarbaldehyde(6109-54-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 6109-54-2(Hazardous Substances Data)

Usage

General Description

2,5-Bis(benzyloxy)benzenecarbaldehyde is a chemical compound with the molecular formula C21H18O3. It is an organic compound that contains a benzene ring structure with two benzyloxy groups and one aldehyde group attached. 2,5-Bis(benzyloxy)benzenecarbaldehyde lies within the scope of aroma compounds and pharmaceuticals, and can be used in the synthesis of various aroma compounds, pharmaceuticals, and organic materials due to its benzyloxy and aldehyde functional groups. Its properties and uses are largely defined by these functional groups, making it a crucial component in chemical research and development.

Upstream product

• 1194-98-5 2,5-Dihydroxybenzaldehyde 
• 100-44-7 benzyl chloride 
• 100-39-0 benzyl bromide 
• 113984-70-6 2,5-bis(tert-butyldimethylsilyloxy)benzaldehyde 

Downstream Products

• 188662-67-1 (E)-3-(2,5-Bis-benzyloxy-phenyl)-1-(6-hydroxy-2,3,4-trimethoxy-phenyl)-propenone 
• 531504-76-4 2,5-dibenzyloxystyrene 
• 1450913-60-6 5-(3-(2-(3-(3-chlorophenyl)ureido)ethylamino)-2-hydroxypropoxy)benzofuran-2-carboxamide 
• 1450913-59-3 ethyl 5-(3-(2-(3-(3-chlorophenyl)ureido)ethylamino)-2-hydroxypropoxy)benzofuran-2-carboxylate 
• 6769-56-8 2-methyl-5-hydroxy-benzofuran 
• 1383813-26-0 (+/-)-6-benzyloxy-2,2-dioxo-3,4-dihydro-2H-2λ6-benzo[e][1,2]oxathiin-4-ol 
• 1383813-22-6 methanesulfonic acid 4-benzyloxy-2-formyl-phenyl ester 
• 1450913-71-9 1-(2-(3-(2-(ethoxymethyl)benzofuran-5-yloxy)-2-hydroxypropylamino)ethyl)-3-(4-hydroxyphenyl)urea 
• 279231-59-3 2-(ethoxymethyl)benzofuran-5-ol 
• 1450913-92-4 5-(benzyloxy)-2-(ethoxymethyl)benzofuran 
• 912462-48-7 (5-(benzyloxy)benzofuran-2-yl)methanol 
• 853599-45-8 5-(benzyloxy)benzo[b]furan-2-carboxylic acid ethyl ester 
• 99370-68-0 5-hydroxy-2-benzofuran-carboxylic acid ethyl ester 
• 1413540-49-4 2-O,5-O-dibenzyl-10,11-epoxy-12,13,14,15-tetranorcurcuhydroquinone 

Relevant articles and documents

Modifications at C(5) of 2-(2-Pyrrolidinyl)-Substituted 1,4-Benzodioxane Elicit Potent α4β2 Nicotinic Acetylcholine Receptor Partial Agonism with High Selectivity over the α3β4 Subtype

A series of diastereomeric 2-(2-pyrrolidinyl)-1,4-benzodioxanes bearing a small, hydrogen-bonding substituent at the 7-, 6-, or 5-position of benzodioxane have been studied for α4β2 and α3β4 nicotinic acetylcholine receptor affinity and activity. Analogous to C(5)H replacement with N and to a much greater extent than decoration at C(7), substitution at benzodioxane C(5) confers very high α4β2/α3β4 selectivity to the α4β2 partial agonism. Docking into the two receptor structures recently determined by cryo-electron microscopy and site-directed mutagenesis at the minus β2 side converge in indicating that the limited accommodation capacity of the β2 pocket, compared to that of the β4 pocket, makes substitution at C(5) rather than at more projecting C(7) position determinant for this pursued subtype selectivity.

6-Substituted 1,2-benzoxathiine-2,2-dioxides are isoform-selective inhibitors of human carbonic anhydrases IX, XII and VA

A series of 6-substituted 2-benzoxathiine-2,2-dioxides were synthesized starting from 2,5-dihydroxybenzaldehyde, and then screened in vitro for their inhibition properties against five human carbonic anhydrase (hCA, EC 4.2.1.1) isoforms. All the compounds

SAR studies of epoxycurcuphenol derivatives on leukemia CT-CD4 cells

Bioactive natural products are a potential source of new pharmaceuticals since they offer new modes of action and more specific activities. The use of derivatization also enables the optimal structure for their biological activity to be determined. In thi